TABLE OF CONTENTS
Volume 29, Issue 12 (December 2004)
Original Articles
Preclinical Research
Rapid Synaptic Plasticity of Glutamatergic Synapses on Dopamine Neurons in the Ventral Tegmental Area in Response to Acute Amphetamine Injection FREE
Lavina J Faleiro, Susan Jones and Julie A Kauer
Neuropsychopharmacology 29: 2115-2125; advance online publication, May 19, 2004; doi:10.1038/sj.npp.1300495
Decreased Amphetamine-Induced Locomotion and Improved Latent Inhibition in Mice Mutant for the M5 Muscarinic Receptor Gene Found in the Human 15q Schizophrenia Region FREE
Haoran Wang, Karen Ng, David Hayes, Xiangrong Gao, Gina Forster, Charles Blaha and John Yeomans
Neuropsychopharmacology 29: 2126-2139; advance online publication, June 23, 2004; doi:10.1038/sj.npp.1300502
Expression of the CS- and US-Pre-Exposure Effects in the Conditioned Taste Aversion Paradigm and Their Abolition Following Systemic Amphetamine Treatment in C57BL6/J Mice FREE
Urs Meyer, De Li Tilly Chang, Joram Feldon and Benjamin K Yee
Neuropsychopharmacology 29: 2140-2148; advance online publication, July 7, 2004; doi:10.1038/sj.npp.1300522
Previous Exposure to Psychostimulants Enhances the Reinstatement of Cocaine Seeking by Nucleus Accumbens AMPA FREE
Nobuyoshi Suto, Lauren M Tanabe, Jennifer D Austin, Elizabeth Creekmore, Chauchau T Pham and Paul Vezina
Neuropsychopharmacology 29: 2149-2159; advance online publication, July 21, 2004; doi:10.1038/sj.npp.1300533
Psychostimulants Induce Low-Frequency Oscillations in the Firing Activity of Dopamine Neurons FREE
Wei-Xing Shi, Chen-Lun Pun and Yan Zhou
Neuropsychopharmacology 29: 2160-2167; advance online publication, July 14, 2004; doi:10.1038/sj.npp.1300534
Individual Differences in Cocaine- and Amphetamine-Induced Activation of Male Sprague–Dawley Rats: Contribution of the Dopamine Transporter FREE
Sophia K Briegleb, Joshua M Gulley, Brian R Hoover and Nancy R Zahniser
Neuropsychopharmacology 29: 2168-2179; advance online publication, August 4, 2004; doi:10.1038/sj.npp.1300536
Amphetamine-Induced Fos is Reduced in Limbic Cortical Regions but not in the Caudate or Accumbens in a Genetic Model of NMDA Receptor Hypofunction FREE
Seiya Miyamoto, John N Snouwaert, Beverly H Koller, Sheryl S Moy, Jeffrey A Lieberman and Gary E Duncan
Neuropsychopharmacology 29: 2180-2188; advance online publication, September 29, 2004; doi:10.1038/sj.npp.1300548
Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical Exercise FREE
Amelia A Russo-Neustadt, Hilda Alejandre, Celithelma Garcia, Autumn S Ivy and Michael J Chen
Neuropsychopharmacology 29: 2189-2199; advance online publication, June 16, 2004; doi:10.1038/sj.npp.1300514
Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs FREE
Elisabeth B Binder, Becky Kinkead, Michael J Owens and Charles B Nemeroff
Neuropsychopharmacology 29: 2200-2207; advance online publication, August 25, 2004; doi:10.1038/sj.npp.1300546
Cytoskeletal Genes Regulation by Chronic Morphine Treatment in Rat Striatum FREE
Cynthia Marie-Claire, Cindie Courtin, Bernard P Roques and Florence Noble
Neuropsychopharmacology 29: 2208-2215; advance online publication, June 16, 2004; doi:10.1038/sj.npp.1300513
Role of Hippocampal CaMKII in Serotonin 5-HT1A Receptor-Mediated Learning Deficit in Rats FREE
Sonia Moyano, Joaquín Del Río and Diana Frechilla
Neuropsychopharmacology 29: 2216-2224; advance online publication, June 16, 2004; doi:10.1038/sj.npp.1300504
Introduction
Thematic Clinical Issue on Late-Life Depression
Introduction to Thematic Clinical Issue of Neuropsychopharmacology in Late-Life Depression FREE
Charles F Reynolds III
Neuropsychopharmacology 29: 2225; advance online publication, October 7, 2004; doi:10.1038/sj.npp.1300566
Original Articles
Thematic Clinical Issue on Late-Life Depression
Effects of Serotonin Transporter Promoter Polymorphisms on Serotonin Function FREE
Gwenn S Smith, Francis E Lotrich, Anil K Malhotra, Annette T Lee, Yilong Ma, Elisse Kramer, Peter K Gregersen, David Eidelberg and Bruce G Pollock
Neuropsychopharmacology 29: 2226-2234; advance online publication, September 8, 2004; doi:10.1038/sj.npp.1300552
Decreased Hippocampal 5-HT2A Receptor Binding in Older Depressed Patients Using [18F]Altanserin Positron Emission Tomography FREE
Yvette I Sheline, Mark A Mintun, Deanna M Barch, Consuelo Wilkins, Abraham Z Snyder and Stephen M Moerlein
Neuropsychopharmacology 29: 2235-2241; advance online publication, September 15, 2004; doi:10.1038/sj.npp.1300555
Preclinical Research
Neuropathologic Correlates of Late-Onset Major Depression FREE
Robert A Sweet, Ronald L Hamilton, Meryl A Butters, Benoit H Mulsant, Bruce G Pollock, David A Lewis, Oscar L Lopez, Steven T DeKosky and Charles F Reynolds III
Neuropsychopharmacology 29: 2242-2250; advance online publication, September 8, 2004; doi:10.1038/sj.npp.1300554
Thematic Clinical Issue on Late-Life Depression
Brain Metabolites and Cognitive Function among Older Depressed and Healthy Individuals Using 2D MR Spectroscopy FREE
Virginia Elderkin-Thompson, M Albert Thomas, Nader Binesh, Jim Mintz, Ebrahim Haroon, Jennifer J Dunkin and Anand Kumar
Neuropsychopharmacology 29: 2251-2257; advance online publication, September 8, 2004; doi:10.1038/sj.npp.1300553
Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression FREE
Carolyn Cidis Meltzer, Julie C Price, Chester A Mathis, Meryl A Butters, Scott K Ziolko, Eydie Moses-Kolko, Sati Mazumdar, Benoit H Mulsant, Patricia R Houck, Brian J Lopresti, Lisa A Weissfeld and Charles F Reynolds
Neuropsychopharmacology 29: 2258-2265; advance online publication, October 13, 2004; doi:10.1038/sj.npp.1300556
Prefrontal Neuropsychological Predictors of Treatment Remission in Late-Life Depression FREE
Guy G Potter, Joshua D Kittinger, H Ryan Wagner, David C Steffens and K Ranga Rama Krishnan
Neuropsychopharmacology 29: 2266-2271; advance online publication, September 1, 2004; doi:10.1038/sj.npp.1300551
Is there a Definition of Remission in Late-Life Depression that Predicts Later Relapse? FREE
Warren D Taylor, Douglas R McQuoid, David C Steffens and K Ranga Rama Krishnan
Neuropsychopharmacology 29: 2272-2277; advance online publication, September 8, 2004; doi:10.1038/sj.npp.1300549
Executive Dysfunction, Heart Disease Burden, and Remission of Geriatric Depression FREE
George S Alexopoulos, Dimitris N Kiosses, Christopher Murphy and Moonseong Heo
Neuropsychopharmacology 29: 2278-2284; advance online publication, September 1, 2004; doi:10.1038/sj.npp.1300557
A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the Future FREE
Warren D Taylor and P Murali Doraiswamy
Neuropsychopharmacology 29: 2285-2299; advance online publication, September 1, 2004; doi:10.1038/sj.npp.1300550
Corrigendum
The Serotonin 5-HT2A Receptors Antagonist M100907 Prevents Impairment in Attentional Performance by NMDA Receptor Blockade in the Rat Prefrontal Cortex FREE
Mirjana Carli, Marta Baviera, Roberto W Invernizzi and Claudia Balducci
Neuropsychopharmacology 29: 2300; doi:10.1038/sj.npp.1300545
